Oral Answers to Questions

Debate between Penny Mordaunt and Jeremy Lefroy

Monday 23rd November 2015 Commons Chamber

[Penny Mordaunt]

Before any drug is prescribed, an individual risk assessment of the patient is undertaken. In addition, as soon as a prescription is entered on to the electronic records system, a warning is flagged to ensure that the prescriber is absolutely sure that the recipient has not had a mental health problem. That policy is audited by defence primary healthcare organisations. If Members have constituents about whom they are concerned, they should encourage them to see their GP or their medical officer.

[Jeremy Lefroy (Stafford) (Con)]

I very much endorse what the hon. Member for Strangford (Jim Shannon) said and I welcome the Minister’s reply. Having suffered the consequences of Lariam myself, I ask her to look at the alternatives, of which there are several that have far fewer negative side-effects.

[Penny Mordaunt]

I thank my hon. Friend and I can reassure him that Lariam is not our first-line drug. However, in certain parts of the world and given the particular medical history of some individuals, the drug is sometimes currently the only course of action. A new drug is coming on line, and it will be looked at.